Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Wilkins HM

From Bioblast
Revision as of 09:33, 30 September 2021 by Beno Marija (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Name Wilkins Heather M, Dr.
Institution University of Kansas Hospital
Address 3901 Rainbow Blvd, KS 66160
City Kansas City
State/Province Kansas (KS)
Country USA
Email [email protected]
Weblink
O2k-Network Lab US KS Kansas City Swerdlow RH, US KS Kansas City Wilkins H


Labels:



Publications

 PublishedReference
Taylor 2024 Pilot Feasibility Stud2024Taylor MK, Burns JM, Choi IY, Herda TJ, Lee P, Smith AN, Sullivan DK, Swerdlow RH, Wilkins HM (2024) Protocol for a single-arm, pilot trial of creatine monohydrate supplementation in patients with Alzheimer's disease. Pilot Feasibility Stud 10:42. https://doi.org/10.1186/s40814-024-01469-5
Tungtur 2021 Sci Rep2021Tungtur SK, Wilkins HM, Rogers RS, Badawi Y, Sage JM, Agbas A, Jawdat O, Barohn RJ, Swerdlow RH, Nishimune H (2021) Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Sci Rep 11:11051.

Abstracts

Add abstract